Highlights from the 2024 HIV Research for Prevention (R4P) Conference

Beatriz Grinsztejn, MD
President, International AIDS Society (IAS)
Head of the STD/AIDS Clinical Research Laboratory
Evandro Chagas National Institute of Infectious Diseases (FIOCRUZ)
Rio de Janeiro, Brasil

Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2024. All rights reserved.

Download Article PDF/Slides    

How to Obtain CME Credit:

Top of page

Click here to take the CME Evaluation and Post-Meeting Survey

About the Presenter:

Top of page

Dr. Beatriz Grinsztejn is an infectious disease physician and researcher with over 30 years of dedication to HIV prevention and care. She is the Director of the FIOCRUZ STI/AIDS Prevention and Therapeutic Clinical Trials Unit, where she leads research focused on advancing the prevention, treatment, and care of HIV, STIs, and emerging infections. Under her leadership, the CTU is affiliated with major international networks, including HPTN and ACTG. Dr. Grinsztejn currently serves as Co-Chair of the HPTN 083 Study and Chair of the ImPrEP CAB-LA Implementation Study, which aimed to evaluate the use of CAB-LA among 1,200 MSM and other sexual and gender minorities in Brazil. Dr. Grinsztejn is the current President-elect of the International AIDS Society (IAS). With a strong foundation in public health and a commitment to social justice, her work focuses on addressing health disparities and improving outcomes for populations at higher vulnerability, including men who have sex with men and transgender individuals.

Learning Objectives:

Top of page

At the completion of this educational activity learners will:
1. Gain awareness of the most significant findings and innovations presented at the HIV R4P conference.
2. Understand the newest scientific discoveries from clinical trials and their implications for real-world HIV prevention.
3. Be able to explore strategies to address challenges limiting the wider adoption of HIV prevention interventions.
4. Assess how recent findings can enhance prevention programs in diverse settings and address ongoing gaps in HIV prevention efforts.

CME Information:

Top of page

This CME activity has approved for AMA PRA Category 1 Credit™ for December 17, 2024, as a live activity. This activity will also be available as an enduring activity from December 24, 2024, through December 16, 2027.

The target audience is all physicians, NPs and PAs involved in or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:

Top of page

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement:

Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:

Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.

- Dr. James F. Braun (Course Director/Program Planner) has no relevant financial relationships to disclose.
- Dr. Roy M. Gulick, MD, MPH (Moderator) has no relevant financial relationships to disclose.
- Dr. Beatriz Grinsztejn, MD (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Advisory board member to Gilead, Merck and ViiV. Dr. Grinsztejn submitted her slides in advance for adequate peer review and supported her presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.

Financial Support:

Top of page

This PRN CME activity is funded in part by unrestricted educational grants from Gilead Sciences and ViiV Healthcare and by a generous charitable contribution from Northwell Health Center for AIDS Research & Treatment.